ATNF: 180 Life Sciences Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.41
Enterprise Value ($M) 4.70
Book Value ($M) 3.73
Book Value / Share 1.89
Price / Book 1.18
NCAV ($M) -5.51
NCAV / Share -2.79
Price / NCAV -0.80

Profitability (mra)
Return on Invested Capital (ROIC) -0.74
Return on Assets (ROA) -0.63
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.19
Current Ratio 0.19

Balance Sheet (mrq) ($M)
Current Assets 1.23
Assets 10.47
Liabilities 6.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Nonrecurring Common Control Intra Entity Transactions Description n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Armistice Capital, Llc 4.99 -95.15

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-12-05 18,600 91,767 20.27
2024-12-04 7,174 41,875 17.13
2024-12-03 15,961 77,912 20.49
2024-12-02 135,032 407,898 33.10

(click for more detail)

Similar Companies
ARTL – Artelo Biosciences, Inc. ASNS – Actelis Networks, Inc.
ASRT – Assertio Holdings, Inc. ATOS – Atossa Therapeutics, Inc.
ATXI – Avenue Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io